18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer

Aim of the present analysis is to investigate the biodistribution and pharmacokinetics of the recently clinically introduced radioligand 18F-PSMA-1007 in patients with biochemical recurrence or progression of prostate cancer (PC) by means of multiparametric (dynamic and whole-body) PET/CT.

Saved in:
Bibliographic Details
Main Authors: Sachpekidis, Christos (Author) , Afshar-Oromieh, Ali (Author) , Kopka, Klaus (Author) , Strauss, D. S. (Author) , Pan, L. (Author) , Haberkorn, Uwe (Author) , Dimitrakopoulou-Strauss, Antonia (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: European journal of nuclear medicine and molecular imaging
Year: 2019, Volume: 47, Issue: 3, Pages: 592-602
ISSN:1619-7089
DOI:10.1007/s00259-019-04569-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-019-04569-0
Get full text
Author Notes:Christos Sachpekidis, A. Afshar-Oromieh, K. Kopka, D.S. Strauss, L. Pan, U. Haberkorn, A. Dimitrakopoulou-Strauss
Description
Summary:Aim of the present analysis is to investigate the biodistribution and pharmacokinetics of the recently clinically introduced radioligand 18F-PSMA-1007 in patients with biochemical recurrence or progression of prostate cancer (PC) by means of multiparametric (dynamic and whole-body) PET/CT.
Item Description:Im Titel ist die Zahl 18 hochgestellt
Published online: 14 November 2019
Gesehen am 02.04.2020
Physical Description:Online Resource
ISSN:1619-7089
DOI:10.1007/s00259-019-04569-0